CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, today announced that the company will be presenting at Rodman & Renshaw’s 8th Annual Healthcare Conference, being held November 6th through 8th. The company’s presentation will take place on Wednesday, November 8th, at 2:50 p.m. EST in the Holmes I Room at the Palace Hotel in New York, New York.
